New stock news | Cofoe Medical Technology (301087.SZ) Hong Kong IPO prospectus invalid
Kang Fu Medical's Hong Kong stock prospectus, submitted on August 29, 2025, has been valid for 6 months and recently expired. Huatai International and BNP PARIBAS were its joint sponsors when the prospectus was submitted.
Cofoe Medical Technology (301087.SZ) submitted its Hong Kong IPO prospectus on August 29, 2025, which has now expired after six months. Huatai International and BNP Paribas were its joint sponsors at the time of submission.
The prospectus shows that Cofoe Medical Technology was established in 2007, specializing in household medical equipment industry, and has always been committed to providing convenient solutions for consumers and patients pursuing high-quality and advanced household medical equipment. It is one of the largest household medical equipment companies in China.
According to Frost & Sullivan data, based on China's sales in 2024, the company ranked second among all household medical equipment companies. During the previous reporting period, Cofoe Medical Technology actively expanded into overseas markets, attracting an increasingly loyal global user base. Currently, Cofoe Medical Technology's global business footprint covers more than 60 countries and regions in Asia, Africa, Europe, and the Americas.
Related Articles

ANDRE JUICE (02218): Li Yufeng has been appointed to replace Yu Haifeng as the signing registered accountant.

SIIC Environment (00807) will distribute a final dividend of 0.011 Singapore dollars per share on May 29th.

Shenwan Hongyuan Group (06806): "22 Shen Hong 02" will pay interest on March 9th.
ANDRE JUICE (02218): Li Yufeng has been appointed to replace Yu Haifeng as the signing registered accountant.

SIIC Environment (00807) will distribute a final dividend of 0.011 Singapore dollars per share on May 29th.

Shenwan Hongyuan Group (06806): "22 Shen Hong 02" will pay interest on March 9th.

RECOMMEND





